InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Tango Therapeutics, Inc.

TNGX Clue Score51
United States Fiscal year ends December CIK 0001819133
$23.81 +5.49% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $23.81 +76.11% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 3 Sep 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue7.7Operating income−52.2Net income−52.0Fiscal year 2021Revenue37.0 +383.8%Operating income−58.2Net income−58.2EPS, diluted−0.94Fiscal year 2022Revenue24.9 −32.9%Operating income−111.1Net income−108.2EPS, diluted−1.23Fiscal year 2023Revenue36.5 +46.9%Operating income−114.2Net income−101.7EPS, diluted−1.08Fiscal year 2024Revenue42.1 +15.2%Operating income−145.6Net income−130.3EPS, diluted−1.19Fiscal year 2025Revenue62.4 +48.3%Operating income−111.3Net income−101.6EPS, diluted−0.87
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 7.7 37.0 24.9 36.5 42.1 62.4
Growth +383.8% −32.9% +46.9% +15.2% +48.3%
Operating income −52.2 −58.2 −111.1 −114.2 −145.6 −111.3
Net income −52.0 −58.2 −108.2 −101.7 −130.3 −101.6
Growth
EPS, diluted n/a −0.94 −1.23 −1.08 −1.19 −0.87
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Operating margin−681.8%Net margin−678.8%Free cash flow margin900.8%Fiscal year 2021Operating margin−157.1%Net margin−157.2%Free cash flow margin−165.7%Fiscal year 2022Operating margin−446.8%Net margin−435.1%Free cash flow margin−469.7%Fiscal year 2023Operating margin−312.6%Net margin−278.5%Free cash flow margin−327.2%Fiscal year 2024Operating margin−346.1%Net margin−309.7%Free cash flow margin−314.4%Fiscal year 2025Operating margin−178.4%Net margin−162.9%Free cash flow margin−224.3%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −681.8% −157.1% −446.8% −312.6% −346.1% −178.4%
Net margin −678.8% −157.2% −435.1% −278.5% −309.7% −162.9%
Free cash flow margin 900.8% −165.7% −469.7% −327.2% −314.4% −224.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow70.1Capital expenditure−1.1Free cash flow69.0Fiscal year 2021Operating cash flow−59.5Capital expenditure−1.8Free cash flow−61.4 −189.0%Fiscal year 2022Operating cash flow−109.1Capital expenditure−7.7Free cash flow−116.8Fiscal year 2023Operating cash flow−118.0Capital expenditure−1.5Free cash flow−119.5Fiscal year 2024Operating cash flow−131.5Capital expenditure−0.8Free cash flow−132.3Fiscal year 2025Operating cash flow−138.9Capital expenditure−1.0Free cash flow−139.9
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 70.1 −59.5 −109.1 −118.0 −131.5 −138.9
Capital expenditure −1.1 −1.8 −7.7 −1.5 −0.8 −1.0
Free cash flow 69.0 −61.4 −116.8 −119.5 −132.3 −139.9
Growth −189.0%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash28.4Shareholders’ equity38.6Fiscal year 2021Cash142.7Shareholders’ equity344.7Fiscal year 2022Cash60.0Shareholders’ equity249.5Fiscal year 2023Cash66.4Shareholders’ equity253.1Fiscal year 2024Cash69.5Shareholders’ equity199.5Fiscal year 2025Cash112.3Shareholders’ equity346.2
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 28.4 142.7 60.0 66.4 69.5 112.3
Shareholders’ equity 38.6 344.7 249.5 253.1 199.5 346.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
7.7 37.0 24.9 36.5 42.1 62.4
Growth +383.8% −32.9% +46.9% +15.2% +48.3%
50.0 77.6 105.9 115.2 143.9 132.2
9.9 17.6 30.0 35.5 43.7 41.5
−52.2 −58.2 −111.1 −114.2 −145.6 −111.3
Growth
−52.0 −57.9 −108.1 −101.6 −130.1 −101.6
0.0 0.3 0.1 0.1 0.2 0.0
−52.0 −58.2 −108.2 −101.7 −130.3 −101.6
Growth
Per share
n/a −0.94 −1.23 −1.08 −1.19 −0.87
n/a −0.94 −1.23 −1.08 −1.19 −0.87
Growth
n/a 62.1 87.8 94.6 109.2 116.2
n/a 62.1 87.8 94.6 109.2 116.2
Growth +41.4% +7.7% +15.5% +6.4%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 52.1% a year over five years.
  • Operating margin is up 503.4 points on five years ago, at -178.4%.
  • A net loss in 6 of 6 years on file.